Future of cardiogenetics

Martina C. Cornel*, Isa Houwink, Christopher Semsarian

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

Cardiogenetics faces two major challenges: identifying index cases and making optimal use of sequencing technologies. Nonexpert physicians need to be actively engaged to identify index cases, not only in cardiology and clinical genetics but also in primary care, population screening, at postmortem, and elsewhere in health care. Training, including e-modules, is needed to update knowledge and skills. An active approach to test family members of diagnosed cases may save lives. With decreasing prices of sequencing technologies, the temptation to sequence everything that is possible might lead to many variants of unknown significance. Patients and their families would be better served by targeted analysis of variants of high predictive value and selecting the DNA test based on the phenotype. Data sharing and more detailed and precise phenotyping will help to better understand the current variants of unknown significance.

Original languageEnglish
Title of host publicationClinical Cardiogenetics
Subtitle of host publicationSecond Edition
PublisherSpringer International Publishing Switzerland
Pages389-393
Number of pages5
ISBN (Electronic)9783319442037
ISBN (Print)9783319442020
DOIs
Publication statusPublished - 30 Nov 2016

Cite this

Cornel, M. C., Houwink, I., & Semsarian, C. (2016). Future of cardiogenetics. In Clinical Cardiogenetics: Second Edition (pp. 389-393). Springer International Publishing Switzerland. https://doi.org/10.1007/978-3-319-44203-7_24